Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGINTERFERON ALFA-2B for Brain neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where PEGINTERFERON ALFA-2B was used for Brain neoplasm.

Most Reported Side Effects for PEGINTERFERON ALFA-2B

Side Effect Reports % Deaths Hosp.
Anaemia 804 19.0% 37 184
Platelet count decreased 593 14.0% 13 96
Pyrexia 440 10.4% 11 89
White blood cell count decreased 420 9.9% 8 61
Haemoglobin decreased 281 6.7% 10 70
Neutrophil count decreased 272 6.4% 7 43
Nausea 269 6.4% 6 80
Rash 269 6.4% 20 60
Fatigue 245 5.8% 4 44
Decreased appetite 224 5.3% 7 65
Blood bilirubin increased 222 5.3% 3 31
Malaise 219 5.2% 13 53
Headache 207 4.9% 7 56
Neutropenia 194 4.6% 21 53
No adverse event 190 4.5% 0 0

Other Indications for PEGINTERFERON ALFA-2B

Chronic hepatitis c (1,927) Hepatitis c (1,246) Malignant melanoma (134) Product used for unknown indication (122) Hepatic cirrhosis (91) Chronic myeloid leukaemia (53) Chronic hepatitis b (32) Hepatitis c virus test positive (20) Hiv infection (15) Essential thrombocythaemia (14)

Other Drugs Used for Brain neoplasm

TEMOZOLOMIDE (286) BEVACIZUMAB (166) PROCARBAZINE (142) ETOPOSIDE (121) CARBOPLATIN (103) VINCRISTINE (93) CYCLOPHOSPHAMIDE (72) CISPLATIN (67) TRAMETINIB DIMETHYL SULFOXIDE (55) BEVACIZUMAB-AWWB (50)

Related Pages

PEGINTERFERON ALFA-2B Full Profile All Brain neoplasm Drugs PEGINTERFERON ALFA-2B Demographics PEGINTERFERON ALFA-2B Timeline